Status | Study |
Not yet recruiting |
Study Name: The Efficacy of Niacin on Hyperphosphatemia in Patients Undergoing Haemodialysis Condition: Hyperphosphatemia Date: 2017-05-21 Interventions: Drug: Niacin tablets |
Recruiting |
Study Name: Decreasing Intakes & Absorption of Phosphorus in Haemodialysis Patients Through Food Choices Condition: Renal Dialysis Hyperphosphatemia Dietary Modification Date: 2017-04-04 Interventions: Other: Current Low Phosphorus Diet Prescription |
Not yet recruiting |
Study Name: Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients Condition: Hyperphosphatemia Date: 2017-03-01 Interventions: Drug: Ferric Citrate One to two tablets of Ferric Citrate phosphorus binder administered by mouth before |
Recruiting |
Study Name: Behavioral Management of Phosphorus in Hemodialysis Patients Condition: Cardiovascular Disease (CKD) Hyperphosphatemia Date: 2016-10-17 Interventions: Behavioral: Education (Edu) Th |
Recruiting |
Study Name: Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia Condition: Hyperphosphatemia Date: 2016-07-14 Interventions: Drug: Nicotinic Acids Nicotini |
Recruiting |
Study Name: An Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia Condition: Hyperphosphatemia Date: 2016-02-17 Interventions: Drug: PA21 (Velphoro®) |
Recruiting |
Study Name: Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD) Condition: Hyperphosphatemia Date: 2016-02-09 Interventions: Drug: sucroferric oxyhydroxide The non-interventional design allows the observation of patients in a bro |
Completed |
Study Name: Dietary Phosphate and Serum Phosphorus Condition: Phosphorus Metabolism Disorders Date: 2015-04-22 |
Completed |
Study Name: Dose Finding Study to Treat High Phosphate Levels in the Blood. Condition: Hyperphosphatemia Date: 2014-03-06 Interventions: Drug: AZD1722 AZD1722, oral ta |
Completed |
Study Name: A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia Condition: Peritoneal Dialysis Hyperphosphatemia Date: 2013-05-07 Interventions: Drug: PA21 |